Research on Optimal Diagnosis and Treatment of Cardiorenal Syndrome
Recruiting · NCT05397392 · Observational (researchers observe without assigning treatment) · Lead sponsor: Nanjing First Hospital, Nanjing Medical University
View the official record on ClinicalTrials.gov →Interventions studied
guideline recommended routine treatment
What this trial is about
To estimate the characteristics, pathogenesis, risk factors and intervention measures for different stages of heart and kidney diseases, and to optimize the curative effects of different treatment schemes
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patients meet the diagnosis of various types of cardiorenal syndrome according to the classification standards of various types formulated by KDIGO and ADQI expert consensus. Different syndromes were identified and classified into five subtypes. Acute CRS (type 1): acute worsening of heart function (AHF-ACS) leading to kidney injury and/or dysfunction. Chronic cardio-renal syndrome (type 2): chronic abnormalities in heart function (CHF-CHD) leading to kidney injury and/or dysfunction. Acute reno-cardiac syndrome (type 3): acute worsening of kidney function (AKI) leading to heart injury and/or dysfunction. Chronic reno-cardiac syndrome (type 4): chronic kidney disease leading to heart injury, disease, and/or dysfunction. Secondary CRS (type 5): systemic conditions leading to simultaneous injury and/or dysfunction of heart and kidney.
Exclusion criteria
- Pregnant or breastfeeding women; Female patients with recent birth plans; Patients who cannot follow up on medications.
Where it is running
1 location listed.
- Study site - Nanjing, China